Novartis Acquires Endocyte For $24 Per Share Or $2.1B In Cash
October 18, 2018 at 08:53 AM EDT
Endocyte announced that it has entered into an agreement and plan of merger with Novartis AG pursuant to which Novartis will acquire Endocyte for $24 per share.
